HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diagnostic value of 123I-IMT SPECT in the follow-up of head and neck cancer.

AbstractBACKGROUND:
Nuclear medicine imaging is increasingly used in the evaluation of tumors of the head and neck. In the current study, we assess the value of single-photon emission tomography (SPECT) using the amino acid tracer L-3-[123I]iodine-alpha-methyl-tyrosine (IMT) for the detection of recurrent head and neck cancer.
PATIENTS AND METHODS:
45 consecutive patients with suspected recurrence of previously treated head and neck cancer were examined by IMT-SPECT using a dual head system with integrated low-dose computed tomography (CT). The accuracy of the IMT-SPECT was evaluated by correlating the findings with results of histology or clinical and CT/MRI (magnetic resonance imaging) follow-up examinations.
RESULTS:
The sensitivity, specificity and accuracy of IMT-SPECT in the detection of recurrent/persistent tumors were 83, 89 and 84.5%, respectively. The positive and negative predictive value amounted to 96.5 and 60%, respectively.
CONCLUSION:
IMT-SPECT using integrated low-dose CT appears to be a helpful complementary imaging tool for the detection of local recurrences and lymph node metastases of head and neck cancer and their differentiation from treatment-induced changes. The advantage of the method is the high positive predictive value in the diagnosis of relapsed tumors. However, a negative IMT-SPECT result does not exclude a recurrence.
AuthorsMichail Plotkin, Reinhard Wurm, David Kuczer, Peter Wust, Roger Michel, Timm Denecke, Juri Ruf, Lorenz Schlenger, Annet Bischoff, Roland Felix, Holger Amthauer
JournalOnkologie (Onkologie) Vol. 29 Issue 4 Pg. 147-52 (Apr 2006) ISSN: 0378-584X [Print] Switzerland
PMID16601370 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Methyltyrosines
  • Radiopharmaceuticals
  • 3-iodo-alpha-methyltyrosine
Topics
  • Female
  • Follow-Up Studies
  • Head and Neck Neoplasms (diagnostic imaging, therapy)
  • Humans
  • Male
  • Methyltyrosines
  • Neoplasm Recurrence, Local (diagnostic imaging, prevention & control)
  • Prognosis
  • Radiopharmaceuticals
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Tomography, Emission-Computed, Single-Photon (methods)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: